
GeneDx Faces Investor Class Action After Stock Collapse
A 49% stock price collapse on May 5, 2026, has triggered a securities class action investigation into GeneDx Holdings. Hagens Berman is representing investors who claim the company misled them regarding the synergy and financial health of its Fabric Genomics acquisition, setting an August 3, 2026, deadline for lead plaintiff applications.



















